News
11-19-2010, 05:23 AM
ZIOPHARM Oncology, Inc. announced today important new preclinical data on the efficacy of darinaparsin (ZinaparTM, or ZIO-101) in various solid tumor models delivered at the EORTC-NCI-AACR International Symposium on Molecular Targets and Cancer Therapeutics being held in Berlin, Germany.
More... (http://www.news-medical.net/news/20101119/ZIOPHARM-announces-data-on-darinaparsin-efficacy-for-solid-tumors-at-EORTC-NCI-AACR-Symposium.aspx)
More... (http://www.news-medical.net/news/20101119/ZIOPHARM-announces-data-on-darinaparsin-efficacy-for-solid-tumors-at-EORTC-NCI-AACR-Symposium.aspx)